Literature DB >> 19752715

AIDS-related and non-AIDS-related mortality in the Asia-Pacific region in the era of combination antiretroviral treatment.

Kathleen Falster1, Jun Yong Choi, Basil Donovan, Chris Duncombe, Brian Mulhall, David Sowden, Jialun Zhou, Matthew G Law.   

Abstract

OBJECTIVE: Although studies have shown reductions in mortality from AIDS after the introduction of combination antiretroviral treatment (cART), little is known about cause-specific mortality in low-income settings in the cART era. We explored predictors of AIDS and non-AIDS mortality and compared cause-specific mortality across high-income and low-income settings in the Asia-Pacific region.
METHODS: We followed patients in the Asia Pacific HIV Observational Database from the date they started cART (or cohort enrolment if cART initiation was identified retrospectively), until the date of death or last follow-up visit. Competing risks methods were used to estimate the cumulative incidence, and to investigate predictors, of AIDS and non-AIDS mortality.
RESULTS: Of 4252 patients, 215 died; 89 from AIDS, 97 from non-AIDS causes and 29 from unknown causes. Age more than 50 years [hazard ratio 4.29; 95% confidence interval (CI) 2.10-8.79] and CD4 cell counts less than or equal to 100 cells/microl (hazard ratio 8.59; 95% CI 5.66-13.03) were associated with an increased risk of non-AIDS mortality. Risk factors for AIDS mortality included CD4 cell counts less than or equal to 100 cells/microl (hazard ratio 34.97; 95% CI 18.01-67.90) and HIV RNA 10 001 or more (hazard ratio 4.21; 95% CI 2.07-8.55). There was some indication of a lower risk of non-AIDS mortality in Asian high-income, and possibly low-income, countries compared to Australia.
CONCLUSION: Immune deficiency is associated with an increased risk of AIDS and non-AIDS mortality. Older age predicts non-AIDS mortality in the cART era. Less conclusive was the association between country-income level and cause-specific mortality because of the relatively high proportion of unknown causes of death in low-income settings.

Entities:  

Mesh:

Year:  2009        PMID: 19752715      PMCID: PMC2879393          DOI: 10.1097/QAD.0b013e328331910c

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  36 in total

1.  Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study.

Authors:  A Mocroft; R Brettle; O Kirk; A Blaxhult; J M Parkin; F Antunes; P Francioli; A D'Arminio Monforte; Z Fox; J D Lundgren
Journal:  AIDS       Date:  2002-08-16       Impact factor: 4.177

2.  Cardio- and cerebrovascular events in HIV-infected persons.

Authors:  A d'Arminio; C A Sabin; A N Phillips; P Reiss; R Weber; O Kirk; W El-Sadr; S De Wit; S Mateu; K Petoumenos; F Dabis; C Pradier; L Morfeldt; J D Lundgren; N Friis-Møller
Journal:  AIDS       Date:  2004-09-03       Impact factor: 4.177

3.  Survival following HIV infection of a cohort followed up from seroconversion in the UK.

Authors:  Fiona M Ewings; Krishnan Bhaskaran; Ken McLean; David Hawkins; Martin Fisher; Sarah Fidler; Richard Gilson; Demelza Nock; Ray Brettle; Margaret Johnson; Andrew Phillips; Kholoud Porter
Journal:  AIDS       Date:  2008-01-02       Impact factor: 4.177

Review 4.  Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures.

Authors:  D Lavanchy
Journal:  J Viral Hepat       Date:  2004-03       Impact factor: 3.728

5.  Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?

Authors:  E Fontas; F van Leth; C A Sabin; N Friis-Møller; M Rickenbach; A d'Arminio Monforte; O Kirk; M Dupon; L Morfeldt; S Mateu; K Petoumenos; W El-Sadr; S de Wit; J D Lundgren; C Pradier; P Reiss
Journal:  J Infect Dis       Date:  2004-03-02       Impact factor: 5.226

Review 6.  Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis.

Authors:  Andrew E Grulich; Marina T van Leeuwen; Michael O Falster; Claire M Vajdic
Journal:  Lancet       Date:  2007-07-07       Impact factor: 79.321

7.  Mortality rates and causes of death in a cohort of HIV-infected and uninfected women, 1993-1999.

Authors:  Dawn K Smith; Lytt I Gardner; Ruby Phelps; Merle E Hamburger; Charles Carpenter; Robert S Klein; Ann Rompalo; Paula Schuman; Scott D Holmberg
Journal:  J Urban Health       Date:  2003-12       Impact factor: 3.671

8.  1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1992-12-18

9.  Combination antiretroviral therapy and the risk of myocardial infarction.

Authors:  Nina Friis-Møller; Caroline A Sabin; Rainer Weber; Antonella d'Arminio Monforte; Wafaa M El-Sadr; Peter Reiss; Rodolphe Thiébaut; Linda Morfeldt; Stephane De Wit; Christian Pradier; Gonzalo Calvo; Matthew G Law; Ole Kirk; Andrew N Phillips; Jens D Lundgren
Journal:  N Engl J Med       Date:  2003-11-20       Impact factor: 91.245

10.  Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks.

Authors:  Abdel Babiker; Janet Darbyshire; Patrizio Pezzotti; Kholoud Porter; Giovanni Rezza; Sarah A Walker; Valerie Beral; Roel Coutinho; Julia Del Amo; Noël Gill; Christine Lee; Laurence Meyer; Freya Tyrer; Francois Dabis; Rodolphe Thiebaut; Sylvie Lawson-Aye; Faroudy Boufassa; Osamah Hamouda; Klaus Fischer; Patrizio Pezzotti; Giovanni Rezza; Giota Touloumi; Angelos Hatzakis; Anastasia Karafoulidou; Olga Katsarou; Ray Brettle; Jorge del Romero; Maria Prins; Birgit van Benthem; Ole Kirk; Court Pederson; Idelfonso Hernández Aguado; Santiago Pérez-Hoyos; Anne Eskild; Johan N Bruun; Mette Sannes; Caroline Sabin; Christine Lee; Anne M Johnson; Andrew N Phillips; Patrick Francioli; Philippe Vanhems; Mathias Egger; Martin Rickenbach; David Cooper; John Kaldor; Lesley Ashton; Jeanette Vizzard; Roberto Muga; Nicholas E Day; Daniela De Angelis
Journal:  Int J Epidemiol       Date:  2002-10       Impact factor: 7.196

View more
  16 in total

1.  Cardiovascular disease-related mortality and factors associated with cardiovascular events in the TREAT Asia HIV Observational Database (TAHOD).

Authors:  R Bijker; A Jiamsakul; E Uy; N Kumarasamy; R Ditango; R Chaiwarith; W W Wong; A Avihingsanon; L P Sun; E Yunihastuti; S Pujari; C D Do; T P Merati; P Kantipong; K V Nguyen; A Kamarulzaman; F Zhang; M P Lee; J Y Choi; J Tanuma; O T Ng; Blh Sim; J Ross; S Kiertiburanakul
Journal:  HIV Med       Date:  2019-01-08       Impact factor: 3.180

2.  A Decade of Combination Antiretroviral Treatment in Asia: The TREAT Asia HIV Observational Database Cohort.

Authors: 
Journal:  AIDS Res Hum Retroviruses       Date:  2016-05-03       Impact factor: 2.205

3.  HIV and aging: insights from the Asia Pacific HIV Observational Database (APHOD).

Authors:  N Han; S T Wright; C C O'Connor; J Hoy; S Ponnampalavanar; M Grotowski; H X Zhao; A Kamarulzaman
Journal:  HIV Med       Date:  2014-11-18       Impact factor: 3.180

4.  Currently available medications in resource-rich settings may not be sufficient for lifelong treatment of HIV.

Authors:  James Jansson; David P Wilson; Andrew Carr; Kathy Petoumenos; Mark A Boyd
Journal:  AIDS       Date:  2013-05-15       Impact factor: 4.177

5.  Causes of Death in Hospitalized HIV Patients in the Early Anti-Retroviral Therapy Era.

Authors:  M Lartey; A Asante-Quashie; A Essel; E Kenu; V Ganu; A Neequaye
Journal:  Ghana Med J       Date:  2015-03

6.  Polymorphisms in the CD14 and TLR4 genes independently predict CD4+ T-cell recovery in HIV-infected individuals on antiretroviral therapy.

Authors:  Yean K Yong; Esaki M Shankar; Ajantha Solomon; Tim Spelman; Christopher K Fairley; Julian H Elliott; Jennifer Hoy; Paul U Cameron; Adeeba Kamarulzaman; Sharon R Lewin
Journal:  AIDS       Date:  2016-09-10       Impact factor: 4.177

7.  Long-term survival in HIV positive patients with up to 15 Years of antiretroviral therapy.

Authors:  Hamish McManus; Catherine C O'Connor; Mark Boyd; Jennifer Broom; Darren Russell; Kerrie Watson; Norman Roth; Phillip J Read; Kathy Petoumenos; Matthew G Law
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

8.  Does use of antiretroviral therapy regimens with high central nervous system penetration improve survival in HIV-infected adults?

Authors:  H McManus; P C K Li; D Nolan; M Bloch; S Kiertiburanakul; J Y Choi; B Mulhall; K Petoumenos; J Zhou; M Law; B J Brew; E Wright
Journal:  HIV Med       Date:  2011-08-07       Impact factor: 3.094

9.  Laboratory and clinical predictors of disease progression following initiation of combination therapy in HIV-infected adults in Thailand.

Authors:  Trinh Duong; Gonzague Jourdain; Nicole Ngo-Giang-Huong; Sophie Le Cœur; Pacharee Kantipong; Sudanee Buranabanjasatean; Prattana Leenasirimakul; Sriprapar Ariyadej; Somboon Tansuphasawasdikul; Suchart Thongpaen; Marc Lallemant
Journal:  PLoS One       Date:  2012-08-15       Impact factor: 3.240

10.  Rates and factors associated with major modifications to first-line combination antiretroviral therapy: results from the Asia-Pacific region.

Authors:  Stephen Wright; Mark A Boyd; Evy Yunihastuti; Matthew Law; Thira Sirisanthana; Jennifer Hoy; Sanjay Pujari; Man Po Lee; Kathy Petoumenos
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.